Enhancing Computational Efficiency in High-Dimensional Bayesian Analysis: Applications to Cancer Genomics

TL;DR

This paper evaluates the Two-Block Gibbs sampler's efficiency in high-dimensional Bayesian models, demonstrating its advantages over the Three-Block Gibbs sampler in cancer genomics applications, with improved convergence and reduced computational costs.

Contribution

It introduces the 2BG sampler as a more efficient alternative to 3BG in high-dimensional Bayesian shrinkage models, with practical applications in cancer genomics.

Findings

2BG outperforms 3BG in convergence speed

2BG reduces computational costs significantly

Effective feature selection in cancer gene expression data

Abstract

In this study, we present a comprehensive evaluation of the Two-Block Gibbs (2BG) sampler as a robust alternative to the traditional Three-Block Gibbs (3BG) sampler in Bayesian shrinkage models. Through extensive simulation studies, we demonstrate that the 2BG sampler exhibits superior computational efficiency and faster convergence rates, particularly in high-dimensional settings where the ratio of predictors to samples is large. We apply these findings to real-world data from the NCI-60 cancer cell panel, leveraging gene expression data to predict protein expression levels. Our analysis incorporates feature selection, identifying key genes that influence protein expression while shedding light on the underlying genetic mechanisms in cancer cells. The results indicate that the 2BG sampler not only produces more effective samples than the 3BG counterpart but also significantly reduces computational costs, thereby enhancing the applicability of Bayesian methods in high-dimensional data analysis. This contribution extends the understanding of shrinkage techniques in statistical modeling and offers valuable insights for cancer genomics research.